A number of clinical trials of PD-1 inhibitors for the treatment of CCA are ongoing, and several case reports and clinical findings suggest that PD-1 inhibitors have therapeutic effects in CCA (11, 12, 29–31). The gene discussed is PDCD1; the disease is cholangiocarcinoma.